Affiliations 

  • 1 Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore
  • 2 Centre for Outbreak Preparedness, Duke-NUS Medical School, Singapore, Singapore
  • 3 Centre for Outbreak Preparedness, Duke-NUS Medical School, Singapore, Singapore. rukie.dealwis@duke-nus.edu.sg
  • 4 Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
  • 5 Department of Laboratory Services, Ministry of Health, Bandar Seri Begawan, Brunei
  • 6 National Institute of Health (NIH), Islamabad, Pakistan
  • 7 Directorate of Pharmacy and Medical Devices, Ministry of Health, Jakarta, Indonesia
  • 8 Malaysia Genome and Vaccine Institute (MGVI), Selangor, Malaysia
  • 9 National Institute of Public Health, Phnom Penh, Cambodia
  • 10 Mahidol University, Nakhon Pathom, Thailand
  • 11 World Health Organisation country office for Nepal, Kathmandu, Nepal
  • 12 Pasteur Institute, Nha Trang, Vietnam
  • 13 National Public Health Laboratory, Kathmandu, Nepal
  • 14 Institut Pasteur du Cambodge (IPC), Phnom Penh, Cambodia
  • 15 National Institute of Hygien and Epidemiology (NIHE), Nha Trang, Vietnam
  • 16 Department of Medical Sciences, Medical Life Science Institute, Bangkok, Thailand
  • 17 University of Sri Jayewardenepura, Nugegoda, Sri Lanka
  • 18 National Institute of Allergy and Infectious Diseases, National Institutes of Health, Phnom Penh, Cambodia
  • 19 Health Policy Agency, Ministry of Health, Jakarta, Indonesia
  • 20 Pasteur Institute, Ho Chi Minh City, Vietnam
  • 21 Aga Khan University, Karachi, Pakistan
  • 22 International Centre for Diarrhoeal Disease Research (icddr,b), Dhaka, Bangladesh
  • 23 Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Quai Fa Ngum, Vientiane, Laos
  • 24 Philippine Genome Center, University of the Philippines, Luzon, Philippines
  • 25 National Health Laboratory, Department of Medical Service, Ministry of Health, Yangon, Myanmar
  • 26 Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh
  • 27 Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam
  • 28 Research Institute for Tropical Medicine (RITM), Quezon, Philippines
  • 29 Institute for Medical Research, Selangor, Malaysia
  • 30 Department of Medical Research, Ministry of Health, Yangon, Myanmar
  • 31 Ministry of Health, Colombo, Sri Lanka
  • 32 National Centre for Laboratory and Epidemiology (NCLE), Vientiane, Laos
  • 33 SingHealth Duke-NUS Global Health Institute, Singapore, Singapore
  • 34 Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore
Nat Microbiol, 2024 Oct;9(10):2738-2747.
PMID: 39317773 DOI: 10.1038/s41564-024-01809-4

Abstract

Asia remains vulnerable to new and emerging infectious diseases. Understanding how to improve next generation sequencing (NGS) use in pathogen surveillance is an urgent priority for regional health security. Here we developed a pathogen genomic surveillance assessment framework to assess capacity in low-resource settings in South and Southeast Asia. Data collected between June 2022 and March 2023 from 42 institutions in 13 countries showed pathogen genomics capacity exists, but use is limited and under-resourced. All countries had NGS capacity and seven countries had strategic plans integrating pathogen genomics into wider surveillance efforts. Several pathogens were prioritized for human surveillance, but NGS application to environmental and human-animal interface surveillance was limited. Barriers to NGS implementation include reliance on external funding, supply chain challenges, trained personnel shortages and limited quality assurance mechanisms. Coordinated efforts are required to support national planning, address capacity gaps, enhance quality assurance and facilitate data sharing for decision making.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.